Navidea Biopharmaceuticals - 31 Year Stock Price History | NAVB
- The all-time high Navidea Biopharmaceuticals stock closing price was 432.50 on February 21, 1996.
- The Navidea Biopharmaceuticals 52-week high stock price is 0.31, which is 287.5% above the current share price.
- The Navidea Biopharmaceuticals 52-week low stock price is 0.06, which is 25% below the current share price.
- The average Navidea Biopharmaceuticals stock price for the last 52 weeks is 0.12.
Navidea Biopharmaceuticals Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2023 | 0.1789 | 0.2700 | 0.3428 | 0.0660 | 0.0779 | -62.90% |
2022 | 0.6179 | 1.2000 | 1.2000 | 0.1770 | 0.2100 | -79.00% |
2021 | 1.7931 | 2.2700 | 2.9000 | 1.0000 | 1.0000 | -53.49% |
2020 | 2.2506 | 1.2900 | 4.9500 | 0.7000 | 2.1500 | 70.63% |
2019 | 1.5742 | 2.2931 | 3.6000 | 0.5000 | 1.2600 | -38.63% |
2018 | 5.1365 | 7.7800 | 8.1980 | 2.0531 | 2.0531 | -71.37% |
2017 | 9.5384 | 12.9260 | 15.4620 | 6.8740 | 7.1700 | -43.76% |
2016 | 16.8253 | 25.8000 | 30.0000 | 6.0000 | 12.7500 | -52.07% |
2015 | 33.8508 | 38.6000 | 48.2000 | 24.8000 | 26.6000 | -29.63% |
2014 | 30.9714 | 40.0000 | 41.2000 | 20.4000 | 37.8000 | -8.70% |
2013 | 51.8183 | 57.6000 | 68.2000 | 28.0000 | 41.4000 | -26.86% |
2012 | 62.1328 | 54.8000 | 93.6000 | 43.8000 | 56.6000 | 8.02% |
2011 | 65.4746 | 42.4000 | 109.6000 | 39.0000 | 52.4000 | 27.18% |
2010 | 36.5064 | 23.4000 | 43.4000 | 23.4000 | 41.2000 | 68.85% |
2009 | 18.5474 | 11.2200 | 28.0000 | 9.0000 | 24.4000 | 114.04% |
2008 | 10.6386 | 6.4000 | 16.8000 | 6.4000 | 11.4000 | 99.30% |
2007 | 5.3311 | 5.0000 | 9.8000 | 3.8000 | 5.7200 | 19.17% |
2006 | 5.5200 | 5.0000 | 7.2000 | 4.6000 | 4.8000 | -2.04% |
2005 | 7.5133 | 12.0000 | 13.8000 | 4.9000 | 4.9000 | -58.12% |
2004 | 10.2239 | 6.4000 | 20.0000 | 5.8000 | 11.7000 | 88.71% |
2003 | 4.0484 | 2.6000 | 9.5000 | 2.0320 | 6.2000 | 138.46% |
2002 | 5.2536 | 8.4000 | 10.0000 | 1.5000 | 2.6000 | -69.05% |
2001 | 10.2726 | 8.1200 | 18.4000 | 7.0000 | 8.4000 | 0.00% |
2000 | 17.5417 | 9.0000 | 60.0000 | 7.5000 | 8.4000 | -3.89% |
1999 | 14.4229 | 17.5000 | 36.2600 | 6.2000 | 8.7400 | -39.20% |
1998 | 59.1141 | 127.5000 | 127.5000 | 10.0000 | 14.3760 | -88.02% |
1997 | 261.0421 | 302.6000 | 357.6000 | 120.0000 | 120.0000 | -60.99% |
1996 | 327.0848 | 315.0000 | 432.5000 | 215.0000 | 307.6000 | -4.65% |
1995 | 165.0156 | 30.0000 | 398.2000 | 30.0000 | 322.6000 | 975.33% |
1994 | 88.4839 | 123.7600 | 145.0000 | 23.7600 | 30.0000 | -76.00% |
1993 | 121.7964 | 122.5000 | 155.0000 | 105.0000 | 125.0000 | 4.17% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.004B | $0.000B |
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $220.921B | 26.90 |
Intuitive Surgical (ISRG) | United States | $141.815B | 88.52 |
Edwards Lifesciences (EW) | United States | $57.273B | 37.91 |
DexCom (DXCM) | United States | $53.772B | 92.37 |
IQVIA Holdings (IQV) | United States | $45.841B | 27.19 |
IDEXX Laboratories (IDXX) | United States | $44.833B | 53.58 |
Alcon (ALC) | Switzerland | $41.065B | 30.28 |
STERIS (STE) | Ireland | $22.285B | 26.38 |
Waters (WAT) | United States | $20.436B | 29.38 |
Hologic (HOLX) | United States | $18.156B | 20.04 |
SONOVA HOLDING (SONVY) | Switzerland | $17.399B | 0.00 |
ShockWave Medical (SWAV) | United States | $12.065B | 83.36 |
Sysmex ADR (SSMXY) | Japan | $11.407B | 35.78 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.361B | 14.03 |
Teleflex (TFX) | United States | $10.535B | 16.56 |
Penumbra (PEN) | United States | $8.762B | 108.32 |
Masimo (MASI) | United States | $7.645B | 42.87 |
Globus Medical (GMED) | United States | $7.183B | 22.77 |
Glaukos (GKOS) | United States | $4.585B | 0.00 |
Integer Holdings (ITGR) | United States | $3.844B | 24.64 |
LivaNova (LIVN) | United Kingdom | $3.015B | 19.88 |
Elekta AB (EKTAY) | Sweden | $2.904B | 19.92 |
Inari Medical (NARI) | United States | $2.747B | 474.00 |
Integra LifeSciences Holdings (IART) | United States | $2.738B | 11.23 |
PROCEPT BioRobotics (PRCT) | United States | $2.489B | 0.00 |
TransMedics (TMDX) | United States | $2.424B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.388B | 20.19 |
Tandem Diabetes Care (TNDM) | United States | $2.317B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.904B | 0.00 |
RxSight (RXST) | United States | $1.874B | 0.00 |
Veracyte (VCYT) | United States | $1.586B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.997B | 0.00 |
Paragon 28 (FNA) | United States | $0.987B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.919B | 17.01 |
Artivion (AORT) | United States | $0.891B | 103.00 |
Treace Medical Concepts (TMCI) | United States | $0.763B | 0.00 |
OPKO Health (OPK) | United States | $0.746B | 0.00 |
Silk Road Medical (SILK) | United States | $0.733B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.682B | 0.00 |
SiBone (SIBN) | United States | $0.650B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.579B | 19.64 |
IRadimed (IRMD) | United States | $0.549B | 31.89 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.535B | 0.00 |
Nevro (NVRO) | United States | $0.525B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.463B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.377B | 12.69 |
CVRx (CVRX) | United States | $0.376B | 0.00 |
NeuroPace (NPCE) | United States | $0.358B | 0.00 |
AxoGen (AXGN) | United States | $0.336B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.262B | 0.00 |
Sight Sciences (SGHT) | United States | $0.257B | 0.00 |
Accuray (ARAY) | United States | $0.241B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.229B | 0.00 |
908 Devices (MASS) | United States | $0.229B | 0.00 |
AngioDynamics (ANGO) | United States | $0.227B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.206B | 0.00 |
Semler Scientific (SMLR) | United States | $0.201B | 10.81 |
Inogen (INGN) | United States | $0.186B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.181B | 0.00 |
Neuronetics (STIM) | United States | $0.143B | 0.00 |
Delcath Systems (DCTH) | United States | $0.125B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.118B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
Envoy Medical (COCH) | United States | $0.076B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.073B | 0.00 |
Hyperfine (HYPR) | United States | $0.072B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.071B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.064B | 130.67 |
Vasomedical (VASO) | United States | $0.057B | 4.36 |
InspireMD (NSPR) | Israel | $0.054B | 0.00 |
Autonomix Medical (AMIX) | $0.052B | 0.00 | |
Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.048B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.048B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
LENSAR (LNSR) | United States | $0.043B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
DarioHealth (DRIO) | United States | $0.041B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.035B | 0.00 |
Spectral AI (MDAI) | United States | $0.034B | 0.00 |
Precision Optics (POCI) | United States | $0.034B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
PAVmed (PAVM) | United States | $0.025B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.022B | 0.00 |
PetVivo Holdings (PETV) | United States | $0.018B | 0.00 |
Check-Cap (CHEK) | Israel | $0.016B | 0.00 |
NexGel (NXGL) | United States | $0.015B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.015B | 0.00 |
Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.009B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.007B | 0.00 |
Avinger (AVGR) | United States | $0.005B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |